title: Vibrio cholerae infection, novel drug targets and phage therapy.
abstract: Vibrio cholerae is the causative agent of the diarrheal disease cholera. Although antibiotic therapy shortens the duration of diarrhea, excessive use has contributed to the emergence of antibiotic resistance in V. cholerae. Mobile genetic elements have been shown to be largely responsible for the shift of drug resistance genes in bacteria, including some V. cholerae strains. Quorum sensing communication systems are used for interaction among bacteria and for sensing environmental signals. Sequence analysis of the ctxB gene of toxigenic V. cholerae strains demonstrated its presence in multiple cholera toxin genotypes. Moreover, bacteriophage that lyse the bacterium have been reported to modulate epidemics by decreasing the required infectious dose of the bacterium. In this article, we will briefly discuss the disease, its clinical manifestation, antimicrobial resistance and the novel approaches to locate drug targets to treat cholera.
authors: Infectious Disease Biology, Institute of Life Sciences, Nalco Square, Bhubaneswar-751023, Orissa, India.
authors: Mobashar Hussain Urf Turabe
authors: MH
authors: Fazil
authors: Durg V
authors: DV
authors: Singh
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001435:Bacteriophages / Q000502:physiology*; D002771:Cholera / Q000382:microbiology* / Q000503:physiopathology; D002772:Cholera Toxin / Q000235:genetics / Q000378:metabolism; D015195:Drug Design; D024881:Drug Resistance, Bacterial; D006801:Humans; D053038:Quorum Sensing / Q000187:drug effects; D014734:Vibrio cholerae / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development / Q000821:virology*
chemical_list: D000900:Anti-Bacterial Agents; D002772:Cholera Toxin